UPDATE: ETF Preview: ETFS, Futures Look to Open with Mild Gains Ahead of Bernanke Speech

By
A A A

Active broad market exchange-traded funds in Thursday's regular session:

SPDR S&P 500 ( SPY ): -0.25%

iShares S&P 500 ( IVV ): +0.24%

PowerShares QQQ ( QQQ ): -0.14%

iShares Russell 2000 ( IWM ): -0.38%

iShares Russell 1000 Growth ( IWF ): -0.20%

iShares MSCI Emerging Markets Index (EEM): -0.72%

United States Oil Fund (USO): -0.67%

SPDR Gold Shares (GLD): -1.16%

Select Financial Sector SPDRS (XLF): -0.73%

Pre-Market Most Active:

SPY, +0.06%

EWJ, -0.60%

VXX, +0.11%

EEM, -0.59%

XLF, +0.10%

Broad Market Indicators

Broad-market exchange-traded funds, including SPY, IWM, IVV and others, were modestly firmer at mid-day. Actively traded PowerShares QQQ ( QQQ ) was up 0.16%.

U.S. stock futures were pointing to a positive open as investors were looking ahead to Federal Reserve Chairman Ben Bernanke's speech at 9:30 am ET, and the start of a two day meeting by financial ministers and central bank governors from G-7. There was no economic data for release today.

Winners and Losers

Financial -

Select Financial Sector SPDRs (XLF) was up 0.10%. Direxion Daily Financial Bull 3X shares (FAS) was up 0.49%. Its bearish counterpart, FAZ, was down 0.56%.

Among financial stocks, Monarch Financial Holdings (MNRK), the holding company for Monarch Bank, announced a 20% increase in the quarterly common stock cash dividend at its annual shareholder meeting. The board of directors declared a regular quarterly cash dividend of $0.06 per common share, payable on May 31, to shareholders of record on May 20.

Technology -

Tech ETFs Technology Select Sector SPDR ETF (XLK), iShares Dow Jones US Technology ETF (IYW), iShares S&P North American Technology ETF (IGM) and iShares S&P North American Technology-Software Index (IGV) were leaning higher.

Semiconductor ETFs, SPDR S&P Semiconductor (XSD) and Semiconductor Sector Index Fund (SOXX) looked to open in the green.

SPDR S&P International Technology Sector ETF (IPK) was headed for a flat to higher open.

In sector news, Yahoo (YHOO) was up 0.46% following reports that YHOO CEO Marissa Mayer may bid for Hulu-TV streaming services.

Energy -

Dow Jones U.S. Energy Fund (IYE) and Energy Select Sector SPDR (XLE) were heading for a firmer start.

In sector news, ArcelorMittal (MT) was up 5.02% after it was upgraded to Buy from Hold by analysts at ING Group following its earnings report.

Commodities -

June crude was down 1.96%; July natural gas was down 1.69%. United States Oil Fund (USO) was down 1.43%. United States Natural Gas Fund (UNG) was down 1.516%.

June gold was down 2.64% and silver for July delivery was down 0.98%. Among rare metal funds, SPDR Gold Trust (GLD) was down 1.79%; iShares Silver Trust (SLV) was down 1.88%.

Consumer -

Consumer ETFs Consumer Staples Select Sector SPDR (XLP), iShares Dow Jones US Consumer Goods (IYK), and Vanguard Consumer Staples ETF (VDC) were pointing to a higher start.

In sector news, Dunkin' Brands Group Inc (DNKN), the parent company of Dunkin' Donuts and Baskin-Robbins, said its board of directors has named Nigel Travis, CEO of Dunkin' Brands, to the additional role of chairman of the board. Travis, 63, succeeds Jon Luther, 69, who is retiring as director and chairman of the board effective May 15.

Power Play -

Healthcare -

Healthcare ETFs Health Care SPDR (XLV), Vanguard Health Care ETF (VHT), and iShares Dow Jones US Healthcare (IYH) were pointing to a negative start. Biotech ETF iShares NASDAQ Biotechnology Index (IBB) was also heading lower.

In corporate news, Eli Lilly (LLY) was off 1.12% after it announced disappointing Phase III clinical trial results from enzastaurin's PRELUDE study, which explored the molecule as a monotherapy in the prevention of relapse in patients with diffuse large B-cell lymphoma (DLBCL) and said it would stop development of the product. It said the study failed to show a statistically significant increase compared to placebo in disease-free survival in patients at high risk of relapse following rituximab-based chemotherapy. There were no new safety findings, and the safety data were consistent with previously disclosed studies.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: IVV , IWF , IWM , QQQ , SPY

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

88,363,013
  • $102.47 ▲ 2.72%
76,664,591
  • $16.60 ▲ 2.09%
75,156,840
  • $13.20 ▼ 5.71%
53,255,668
  • $40.68 ▼ 6.03%
49,564,657
  • $96.87 ▲ 2.63%
42,649,404
  • $9.26 ▲ 1.09%
37,436,329
  • $31.19 ▲ 5.05%
35,538,826
  • $28.28 ▲ 1.25%
As of 10/21/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com